PRINCETON, N.J.— 8월 31, 2022 — Certara, Inc. 글로벌 바이오시뮬레이션 선두기업(Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences:
- Morgan Stanley 20th Annual Global Healthcare Conference
Date and Time: Tuesday, September 13 at 11:45 a.m. ET - Baird Global Healthcare Conference
Date and Time: Wednesday, September 14 at 12:15 p.m. ET
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
Certara 소개
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. 2,00062 Certara의 고객으로는 전 세계 62개국에 걸쳐 2,000개 이상의 글로벌 바이오 제약 회사, 선도적인 학술 기관 및 주요 규제기관들이 있다.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com
